Peripheral neuropathy does not invariably coexist with autonomic neuropathy in diabetes mellitus

European Journal of Internal Medicine

Volumn 12, Issue 1, 2001, Pages 20-27

  Tentolouris, N ^a   Pagoni, S ^a   Tzonou, A ^a   Katsilambros, N ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Autonomic neuropathy; Diabetes mellitus; Peripheral neuropathy; Somatic neuropathy

Indexed keywords

ADULT; AGED; ARTICLE; AUTONOMIC NEUROPATHY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PAIN; PERIPHERAL NEUROPATHY; PREVALENCE; REGRESSION ANALYSIS;

EID: 0035142801     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0953-6205(00)00128-X     Document Type: Article

References (44)

1. A Multicentre study of the prevalence of diabetic neuropathy in the UK hospital clinical population
2. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study
3. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy and nephropathy in a population based cohort: the Rochester diabetic neuropathy study
4. An overview of diabetic complications
5. Mortality in diabetic autonomic neuropathy
6. Mortality in diabetic patients with cardiovascular autonomic neuropathy
7. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
8. Effect of intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
9. The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT)
10. Peripheral motor nerve function in diabetic autonomic neuropathy
11. Divergent development of autonomic and peripheral somatic neuropathies in NIDDM
12. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus
13. Occurrence, predictors, and clinical significance of autonomic neuropathy in NIDDM
14. Diabetic neuropathy
15. Association of painful and painless diabetic polyneuropathy with different patterns of nerve fiber degeneration and regeneration
16. Variable relationship between peripheral somatic and autonomic neuropathy in patients with different syndromes of diabetic polyneuropathy
17. Differences in peripheral and autonomic nerve function measurements in painful and painless neuropathy
18. The value of cardiovascular autonomic function tests: 10 years experience
19. Corrected QT interval in relation to the severity of diabetic autonomic neuropathy
20. Standardized measures in diabetic neuropathy (consensus statement)
21. Cough test to assess cardiovascular autonomic neuropathy reflexes in diabetes
22. Diagnosis and management of diabetic autonomic neuropathy
23. Detection, characterization, and staging of polyneuropathy: assessed in diabetics
24. Painful neuropathy and foot ulceration in diabetic patients
25. Vibration perception threshold: Influence of age, height, sex, and smoking and calculation of accurate values
26. Guidelines for diagnosis and outpatient management of diabetic peripheral neuropathy
27. The pathology of diabetic neuropathy
28. Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy
29. Inhibition of sorbitol dehydrogenase: effects on vascular and neural dysfunction in streptozotocin-induced diabetic rats
30. Impaired rat sciatic nerve sodium-potassium adenosine triphosphatase in acute streptozotocin diabetes and its correction by dietary myo-inositol supplementation
31. Hyperglycemic pseudohypoxia and diabetic complications
32. Nonenzymatic glycosylation of peripheral nerve protein in diabetes mellitus
33. Glycation of rat sciatic nerve tubulin in experimental diabetes mellitus
34. Effects of acute, subacute, and chronic diabetes on carbohydrate and energy metabolism in rat sciatic nerve: relation to mechanisms of peripheral neuropathy
35. Dissociated sensory loss in diabetic autonomic neuropathy
36. Autonomic neuropathy in type 2 diabetic patients is associated with hyperinsulinaemia and hypertriglyceridaemia
37. Autoantibodies against sympathetic ganglia and evidence of cardiac sympathetic dysinnervation in newly diagnosed and long-term IDDM patients
38. Autoantibodies to sympathetic ganglia, GAD, or tyrosine phosphatase in long-term IDDM with and without ECG-based cardiac autonomic neuropathy
39. Autoimmunity in diabetic autonomic neuropathy: does the immune system get on your nerves?
40. An investigation of antibodies to nerve growth factor in diabetic autonomic neuropathy
41. Pathology of autonomic neuropathy in diabetes
42. The role of endogenous nerve growth factor in human diabetic neuropathy
43. Growth factors and diabetic neuropathy
44. The prevalence of symptomatic diabetic neuropathy in an insulin-treated population